Skin Treatment (Pharmacies) - G20

  • G20
  • Revenue in the Skin Treatment market is projected to reach US$13.54bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 4.89%, resulting in a market volume of US$16.39bn by 2028.
  • In global comparison, most revenue will be generated in the United States (US$3,319.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.72 are generated in 2024.

Key regions: Canada, United States, France, Europe, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Skin Treatment (Pharmacies) market in G20 is experiencing significant growth and development due to changing customer preferences and local special circumstances.

Customer preferences:
Customers in the G20 countries have become increasingly conscious about their skin health and appearance. With the rise of social media and the influence of celebrities and influencers, there is a growing emphasis on having flawless skin. As a result, consumers are seeking out skin treatment products that can address their specific concerns, such as acne, aging, and hyperpigmentation. They are also looking for products that are natural, organic, and free from harmful chemicals. Additionally, there is a rising demand for products that offer multiple benefits, such as moisturizing, sun protection, and anti-aging properties.

Trends in the market:
One of the major trends in the Skin Treatment (Pharmacies) market in G20 is the increasing popularity of skincare routines. Consumers are adopting multi-step skincare regimens that involve cleansing, toning, moisturizing, and applying serums and creams. This trend is driven by the belief that a consistent skincare routine can lead to healthier and more youthful-looking skin. As a result, there is a growing demand for products that cater to each step of the skincare routine. Another trend in the market is the growing preference for natural and organic skincare products. Consumers are becoming more aware of the potential harmful effects of synthetic ingredients and are seeking out products that are made from natural and organic ingredients. This trend is driven by the desire for safer and more sustainable skincare options.

Local special circumstances:
The Skin Treatment (Pharmacies) market in each G20 country is influenced by local special circumstances. For example, in countries with high levels of air pollution, there is a greater demand for skincare products that can protect the skin from environmental damage. In countries with hot and humid climates, consumers are more likely to seek out lightweight and oil-free products that do not clog pores. Additionally, cultural factors can also influence customer preferences. For example, in some G20 countries, there is a tradition of using traditional herbal remedies for skincare, leading to a demand for products that incorporate traditional ingredients.

Underlying macroeconomic factors:
The growth and development of the Skin Treatment (Pharmacies) market in G20 are also influenced by underlying macroeconomic factors. For example, rising disposable incomes in some G20 countries have led to an increase in consumer spending on skincare products. Additionally, the aging population in many G20 countries has created a demand for anti-aging skincare products. Economic stability and a growing middle class in some G20 countries have also contributed to the growth of the market. In conclusion, the Skin Treatment (Pharmacies) market in G20 is developing due to changing customer preferences, local special circumstances, and underlying macroeconomic factors. Customers are increasingly seeking out skincare products that can address their specific concerns and offer multiple benefits. There is also a growing preference for natural and organic skincare options. Local special circumstances, such as air pollution and climate, further influence customer preferences. Underlying macroeconomic factors, such as rising disposable incomes and an aging population, also contribute to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)